ask="N/A"
ask_size="N/A"
average_daily_volume="18178"
bid="N/A"
bid_size="N/A"
book_value="0.44"
change="-0.10"
change_from_200_day_moving_average="0.42"
change_from_50_day_moving_average="0.21"
change_from_52_week_high="-2.20"
change_From_52_week_low="2.65"
change_in_percent="-1.71%"
close="5.75"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.46"
ebitda="-11.23M"
eps_estimate_current_year="-0.49"
eps_estimate_next_quarter="-0.11"
eps_estimate_next_year="-0.52"
ex_dividend_date="N/A"
float_shares="3450000"
high="6.14"
high_52_weeks="7.95"
last_trade_date="3/8/2017"
last_trade_price="5.75"
last_trade_size="350"
last_trade_time="4:00pm"
low="5.65"
low_52_weeks="3.10"
market_capitalization="165.08M"
moving_average_200_day="5.33"
moving_average_50_day="5.54"
name="OncoCyte Corporation Common Sto"
notes="N/A"
one_year_target_price="8.88"
open="5.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+7.78%"
percent_change_from_50_day_moving_average="+3.88%"
percent_change_from_52_week_high="-27.67%"
percent_change_from_52_week_low="+85.48%"
previous_close="5.85"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="13.24"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="28709000"
short_ratio="2.98"
stock_exchange="ASE"
symbol="OCX"
volume="34436"
weeks_range_52="3.10 - 7.95"
